Overview
- 53 inspections across 51 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-20.
At a glance
Inspections
53
Sites
51
Observations
15
Career since
Apr 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bora Pharmaceuticals Injectables Inc | 20 Mar 2026 | Human Drugs | On file |
| QOL Medical LLC | 9 Jan 2026 | Human Drugs | On file |
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) | 15 Dec 2025 | Human Drugs | On file |
| YiChang HEC ChangJiang Pharmaceutical Co., Ltd. | 23 Sep 2025 | Human Drugs | On file |
| Alvotech HF | 4 Jul 2025 | Human Drugs | On file |
Sites inspected
Bora Pharmaceuticals Injectables IncBaltimore, United States1 insp.
QOL Medical LLCClearwater, United States1 insp.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing, China1 insp.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.Yidu, China1 insp.
Alvotech HFReykjavik, Iceland1 insp.
Co-investigators
Investigators who share inspections with this person.
Ralph M Bernstein4 shared
Hyung-Yul Lee3 shared
Charles Y Kuo3 shared
Jacek Cieslak3 shared
Arsen Karapetyan3 shared
Michael Shanks3 shared
Kham Phommachanh3 shared
Yi Wang2 shared
Saundrea A Munroe2 shared
Della Shin2 shared
Full investigator report
Get the verbatim findings behind Zhong Li's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site